EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Integrating mTOR Inhibition and Photodynamic Therapy Based on Carrier‐Free Nanodrugs for Breast Cancer Immunotherapy

Jinzhao Liu, Qingyang Lyu, Meicen Wu, Yang Zhou, Tianyi Wang, Yichi Zhang, Ni Fan, Chang Yang, Weiping Wang iD

Advanced Healthcare Materials · 2024

DOI: 10.1002/adhm.202402357 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Jinzhao Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, 999077, China. Hauptthemen laut MEDLINE: Photochemotherapy, Breast Neoplasms, TOR Serine-Threonine Kinases, Immunotherapy. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Conventional photodynamic therapy (PDT) in cancer treatment needs to utilize oxygen to produce reactive oxygen species to eliminate malignant tissues. However, oxygen consumption in tumor microenvironment exacerbates cancer cell hypoxia and may promote vasculature angiogenesis. Since the mammalian target of rapamycin (mTOR) signaling pathway plays a vital role in endothelial cell proliferation and fibrosis, mTOR inhibitor drugs hold the potential to reverse hypoxia‐evoked angiogenesis for improved PDT effect. In this study, a carrier‐free nanodrug formulation composed of Torin 1 as mTORC1/C2 dual inhibitor and Verteporfin as a photosensitizer and Yes‐associated protein inhibitor is developed. These two drug molecules can self‐assemble into stable nanoparticles through π–π stacking and hydrophobic interactions with good long‐term stability. The nanodrugs can prompt synergistic apoptosis, combinational anti‐angiogenesis, and strong immunogenic cell death effects upon near‐infrared light irradiation in vitro. Furthermore, the nanosystem also exhibits improved antitumor effect, anti‐cancer immune response, and distant tumor inhibition through tumor microenvironment remodeling in vivo. In this way, the nanodrugs can reverse PDT‐elicited angiogenesis and promote cancer immunotherapy to eliminate tumor tissues and prevent metastasis. This nanosystem provides insights into integrating mTOR inhibitors and photosensitizers for safe and effective breast cancer treatment in clinical settings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PhotochemotherapyBreast NeoplasmsTOR Serine-Threonine KinasesImmunotherapyNanoparticlesFemaleAnimalsHumansMiceCell Line, TumorPhotosensitizing AgentsMice, Inbred BALB CTumor MicroenvironmentVerteporfinApoptosis

Stichwörter der Autor:innen

anti‐angiogenesiscarrier‐free nanoparticlesimmunogenic cell deathmTOR inhibitionphotodynamic therapysynergistic effect

Substanzen

TOR Serine-Threonine KinasesPhotosensitizing AgentsVerteporfin

Autor:innen und Institutionen

  • State Key Laboratory of Pharmaceutical Biotechnology, The University of Hong Kong, Hong Kong, 999077, China.
  • Department of Pharmacology and Pharmacy, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong, 999077, China.
  • Dr. Li Dak-Sum Research Centre, The University of Hong Kong, Hong Kong, 999077, China.

ORCID-Profile: Weiping Wang

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Liu, J., Lyu, Q., Wu, M., Zhou, Y., Wang, T., Zhang, Y., Fan, N., Yang, C., & Wang, W. (2024). Integrating mTOR Inhibition and Photodynamic Therapy Based on Carrier‐Free Nanodrugs for Breast Cancer Immunotherapy. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202402357

Vancouver

Liu J, Lyu Q, Wu M, Zhou Y, Wang T, Zhang Y, et al. Integrating mTOR Inhibition and Photodynamic Therapy Based on Carrier‐Free Nanodrugs for Breast Cancer Immunotherapy. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202402357

BibTeX
@article{Liu2024,
  author = {Liu, Jinzhao and Lyu, Qingyang and Wu, Meicen and Zhou, Yang and Wang, Tianyi and Zhang, Yichi and Fan, Ni and Yang, Chang and Wang, Weiping},
  title = {Integrating mTOR Inhibition and Photodynamic Therapy Based on Carrier‐Free Nanodrugs for Breast Cancer Immunotherapy},
  journal = {Advanced Healthcare Materials},
  year = {2024},
  doi = {10.1002/adhm.202402357}
}
Kostenlos starten →